AKT in Stromal Fibroblasts Controls Invasion of Epithelial Cells
Metrics: PDF 1520 views | HTML 1757 views | ?
Ann-Christin Cichon1,*, Adam Pickard1,*, Simon S. McDade1, Daniel J. Sharpe1, Michael Moran1, Jacqueline A. James1 and Dennis J. McCance1
1 Centre for Cancer Research and Cell Biology, Queen’s University, Belfast, UK
* These authors contributed equally
Dennis J. McCance, email:
Keywords: stroma, invasion, AKT, Caspase 1, HPV, mdm2, interleukin 1, KGF, cancer
Received: June 7, 2013 Accepted: July 11, 2013 Published: July 14, 2013
The tumour microenvironment has an important role in cancer progression and recent reports have proposed that stromal AKT is activated and regulates tumourigenesis and invasion. We have shown, by immuno-fluorescent analysis of oro-pharyngeal cancer biopsies, an increase in AKT activity in tumour associated stromal fibroblasts compared to normal stromal fibroblasts. Using organotypic raft co-cultures, we show that activation of stromal AKT can induce the invasion of keratinocytes expressing the HPV type 16 E6 and E7 proteins, in a Keratinocyte Growth Factor (KGF) dependent manner. By depleting stromal fibroblasts of each of the three AKT isoforms independently, or through using isoform specific inhibitors, we determined that stromal AKT2 is an essential regulator of invasion and show in oro-pharyngeal cancers that AKT2 specific phosphorylation events are also identified in stromal fibroblasts. Depletion of stromal AKT2 inhibits epithelial invasion through activating a protective pathway counteracting KGF mediated invasions. AKT2 depletion in fibroblasts stimulates the cleavage and release of IL1B from stromal fibroblasts resulting in down-regulation of the KGF receptor (fibroblast growth factor receptor 2B (FGFR2B)) expression in the epithelium. We also show that high IL1B is associated with increased overall survival in a cohort of patients with oro-pharyngeal cancers. Our findings demonstrate the importance of stromal derived growth factors and cytokines in regulating the process of tumour cell invasion.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.